Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
49 hedge funds and large institutions have $64.6M invested in Tobira Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 12 closing their positions.
133% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 12
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
48% more funds holding
Funds holding: 33 → 49 (+16)
35% more capital invested
Capital invested by funds: $47.9M → $64.6M (+$16.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$15.3M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$6.41M |
| 3 |
PA
Perceptive Advisors
New York
|
+$5.81M |
| 4 |
VAM
Visium Asset Management
New York
|
+$4.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$3.04M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.5M |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$2.5M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.66M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.58M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFM
51
Sphera Funds Management
Tel Aviv,
Israel
| – | -$2.5M | -22,222 | Closed |
|
|
WC
52
Wexford Capital
West Palm Beach,
Florida
| – | -$2.5M | -22,222 | Closed |
|
|
53
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.58M | -14,018 | Closed |
|
|
RFC
54
Russell Frank Company
Seattle,
Washington
| – | -$411K | -6,964 | Closed |
|
|
PAM
55
Panagora Asset Management
Boston,
Massachusetts
| – | -$486K | -4,313 | Closed |
|
|
CS
56
Credit Suisse
Zurich,
Switzerland
| – | -$418K | -3,711 | Closed |
|
|
SC
57
Sophrosyne Capital
New York
| – | -$310K | -2,744 | Closed |
|
|
SIM
58
Spark Investment Management
New York
| – | -$176K | -1,578 | Closed |
|
|
BCMU
59
BlueCrest Capital Management (UK)
St. Peter Port,
Guernsey
| – | -$167K | -1,478 | Closed |
|
|
TC
60
TradeLink Capital
Chicago,
Illinois
| – | -$13K | -111 | Closed |
|
TBRA Hedge Fund Activity: Q2 2014 in Review
49 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q2 2014, worth a combined $64.6M — up 35% from $47.9M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new TBRA positions and 12 closed out — a net gain of 16 holders — while 12 added to existing stakes and 6 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $15.3M. The largest seller was EAM Investors, exiting entirely with an estimated $3.04M sold.
- 49 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q2 2014, up from 33 in Q1 2014.
- Funds reported $64.6M of Tobira Therapeutics, Inc. Common Stock stock for Q2 2014, up 35% quarter-over-quarter.
- 28 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q2 2014 and 12 closed out, a net change of +16 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q2 2014 was Gilder Gagnon Howe & Co, an estimated $15.3M added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q2 2014 was EAM Investors, an estimated $3.04M sold.
Based on aggregated 13F filings for Q2 2014.